BREAKING
Health & Injury Recovery

Soft Tissue Injury Treatment in 2026: What Works, What Doesn't, and What's New

Sports Editor 27 April 2026 - 23:27 548 views 116
From platelet-rich plasma to extracorporeal shockwave therapy, the treatment landscape for muscle, tendon, and ligament injuries has expanded. The evidence for each approach.

The treatment of soft tissue injuries — muscle tears, tendinopathies, ligament sprains — has been one of the most actively researched areas of sports medicine for the past decade, producing a treatment landscape that is simultaneously more evidence-rich and more confusing than at any previous point. Athletes and their medical teams now have access to more treatment options than ever before, including several with compelling theoretical mechanisms and commercial momentum that the clinical evidence has not consistently supported. Understanding what actually works, at what injury stage, and for which specific conditions is essential for making sound treatment decisions.

The Evidence for Established Treatments

The foundation of soft tissue injury management — relative rest, load management, progressive mechanical loading through rehabilitation, and time — remains the most evidence-supported approach for the majority of soft tissue injuries. The evidence for "relative rest" rather than complete rest has strengthened consistently: controlled mechanical loading during healing promotes organised collagen alignment and faster return of function compared to immobilisation in virtually all soft tissue injury types. The specific loading parameters — how much, how frequently, what type of movement — are the domain of specialised sports physiotherapy and vary significantly between injury types and stages.

For tendinopathies specifically, eccentric and heavy slow resistance loading programmes — protocols developed by researchers including Hakan Alfredson and Jill Cook — have the strongest evidence base across multiple tendon locations and patient populations. The mechanism involves mechanical stimulation of tenocyte activity and matrix remodelling, producing structural improvements that correlate with symptom resolution. Compliance is a significant practical challenge — the protocols are uncomfortable, the timeline is long, and athletes in acute symptom phases are motivated by symptom relief rather than tissue remodelling — but the long-term outcomes for athletes who complete the protocols are substantially better than for those who use symptom management alone.

The Evidence for Newer and Emerging Treatments

Platelet-rich plasma (PRP) injection — concentrating autologous platelets and injecting the preparation into the injured tissue to stimulate healing — is among the most widely used "advanced" soft tissue treatments in sports medicine. The evidence for PRP is more mixed than its commercial adoption suggests. For lateral epicondylitis (tennis elbow) and patellar tendinopathy, there is reasonable evidence of benefit over control conditions in well-designed trials. For most other soft tissue applications — rotator cuff tendinopathy, hamstring injuries, plantar fasciitis — the evidence is inconsistent, with high-quality trials frequently failing to demonstrate superiority over saline injection controls.

The theoretical basis for PRP is sound — concentrated growth factors should stimulate tissue healing — and the inconsistency of clinical trial results may reflect heterogeneity in PRP preparation methods, injection technique, patient selection, and rehabilitation protocols rather than absence of a true biological effect. The current evidence supports PRP as a reasonable option for specific tendinopathy presentations where other treatments have failed, but does not support its routine use as a primary treatment for most soft tissue injuries.

Extracorporeal shockwave therapy (ESWT) has stronger evidence than PRP for several conditions, particularly calcific rotator cuff tendinopathy and plantar fasciitis. Multiple well-designed randomised trials support its efficacy, and it is now considered a first-line treatment for these conditions in many sports medicine guidelines. Its mechanism — stimulating neovascularisation and collagen remodelling through acoustic pressure waves — is well established, and the dose-response relationship is better understood than for many other physical modalities.

Dry Needling and Its Evidence Base

Dry needling — the insertion of acupuncture needles into trigger points or specific muscle locations without injection of substance — is widely used by sports physiotherapists and has a mixed evidence base. For acute pain relief and short-term improvement in muscle function, there is reasonable evidence of effect. For longer-term structural outcomes in soft tissue injury, the evidence is less compelling. The clinical utility of dry needling as an adjunct to loading-based rehabilitation — providing enough short-term pain relief to allow therapeutic exercise — is supported by practice experience even where the evidence for standalone benefit is limited.

Making Sense of Treatment Decisions in Practice

For athletes navigating treatment decisions for soft tissue injuries, the most useful framework is to prioritise treatments with the strongest evidence base, to view symptom-based treatments as bridges to loading-based rehabilitation rather than alternatives to it, and to be appropriately sceptical of treatments promoted primarily through commercial channels rather than peer-reviewed clinical evidence. Working with a sports physiotherapist who is familiar with current evidence and who builds treatment plans around progressive loading rather than passive modalities alone gives athletes the best probability of achieving durable recovery rather than temporary symptom management.

Related Articles
Comments
No comments yet. Be the first to comment!
Add a Comment
Your comment will be reviewed before publishing